Table 1 Demographic information dependent on genotype.

From: 5-HTTLPR does not moderate the effect of attention bias modification for depression: a randomized sham-controlled trial

 

SS (n = 59)

LS (n = 148)

LL (n = 56)

p

V / η2p

Sex (male/female)

14/45

45/103

18/38

0.55

0.032

Age

42.3 (13.8)

41.0 (13.0)

39.0 (13.0)

0.39

0.007

ISCEDa

6.0 (0.9)

5.9 (1.2)

6.1 (1.1)

0.47

0.006

Current use of SSRI/SNRI (%)

11 (18.6)

44 (29.7)

16 (28.6)

0.26

0.031

HDRS pre

9.4 (5.6)

8.6 (5.3)

9.2 (6.2)

0.57

0.004

HDRS post

8.5 (6.1)

8.7 (5.6)

10.4 (11.2)

0.97

0.000

BDI-II pre

15.6 (11.5)

14.0 (9.5)

14.5 (10.7)

0.60

0.004

BDI-II post

12.2 (11.0)

11.3 (9.6)

10.4 (9.3)

0.65

0.003

BAI pre

9.9 (10.0)

9.0 (8.1)

10.1 (9.3)

0.64

0.003

BAI post

7.9 (8.3)

7.2 (7.2)

7.9 (8.7)

0.77

0.002

AB pre

−0.06 (27.7)

−0.02 (28.6)

−0.31 (25.9)

1.00

0.000

AB post

5.5 (21.1)

0.22 (16.6)

7.7 (14.9)

0.01

0.034

  1. aISCED level is missing for 13 participants.
  2. Note. Values represent mean and standard deviation, or frequency. For categorical variables, p-values are based on Chi-square-tests, and for continuous variables univariate analysis of variance, with Cramér’s V and partial eta squared as corresponding effect size parameters, respectively.
  3. AB attentional bias, BAI Beck’s anxiety inventory, BDI-II Beck’s depression inventory-II, HDRS hamilton depression rating scale, SNRI serotonin norepinephrine reuptake inhibitor, SSRI selective serotonin reuptake inhibitor.
Back to article page